Gene: PLK3
Official Full Name: polo like kinase 3provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the highly conserved polo-like kinase family of serine/threonine kinases. Members of this family are characterized by an amino-terminal kinase domain and a carboxy-terminal bipartite polo box domain that functions as a substrate-binding motif and a cellular localization signal. Polo-like kinases are important regulators of cell cycle progression. This gene has also been implicated in stress responses and double-strand break repair. In human cell lines, this protein is reported to associate with centrosomes in a microtubule-dependent manner, and during mitosis, the protein becomes localized to the mitotic apparatus. Expression of a kinase-defective mutant results in abnormal cell morphology caused by changes in microtubule dynamics and mitotic arrest followed by apoptosis. [provided by RefSeq, Sep 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08170 | PLK3 Knockout cell line (HeLa) | Human | PLK3 | 1:3~1:6 | Negative | Online Inquiry |
KO08171 | PLK3 Knockout cell line (HCT 116) | Human | PLK3 | 1:2~1:4 | Negative | Online Inquiry |
KO08172 | PLK3 Knockout cell line (HEK293) | Human | PLK3 | 1:3~1:6 | Negative | Online Inquiry |
KO08173 | PLK3 Knockout cell line (A549) | Human | PLK3 | 1:3~1:4 | Negative | Online Inquiry |
PLK3 Gene Knockout Cell Lines are advanced cellular models specifically engineered to lack functional expression of the Polo-like kinase 3 (PLK3) gene. This knockout model allows for the in-depth exploration of PLK3’s role in fundamental cellular processes, including cell cycle regulation, DNA damage response, and apoptosis. By utilizing CRISPR/Cas9 gene editing technology, these cell lines provide researchers with a dependable platform to study the implications of PLK3 aberrations in various biological contexts.
The key mechanism of action of PLK3 Gene Knockout Cell Lines lies in their ability to simulate physiological conditions that mirror diseases associated with PLK3 dysregulation, such as certain cancers. Researchers using these models can dissect cellular signaling pathways involved in cell proliferation and survival directly linked to the absence of PLK3, facilitating a deeper understanding of tumor biology and potential therapeutic targets.
The scientific importance of these cell lines is underscored by their applicability in both research and clinical settings. In cancer research, for instance, they enable the identification of novel biomarkers and therapeutic vulnerabilities that can be exploited for targeted treatments. Furthermore, these cell lines are invaluable in drug development processes, allowing for the evaluation of PLK3 inhibitors and their efficacy in a controlled cellular environment.
Compared to alternative models, PLK3 Gene Knockout Cell Lines differentiate themselves by providing specificity and reproducibility, essential for generating consistent experimental results. Unlike traditional inhibitor-based approaches, which can yield off-target effects or incomplete signaling pathway inhibition, knockout models ensure that the effects observed are directly correlated with PLK3 suppression.
For researchers and clinicians alike, the value of PLK3 Gene Knockout Cell Lines lies in their robustness and versatility, helping to drive innovations in therapeutic development and expand scientific knowledge. Our company specializes in producing high-quality biological products that are rigorously validated to meet researchers' needs, equipping them with tools that advance their studies and accelerate discoveries in molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.